Table 2.
Immune parameters | L | T | EC | P | L | T | EC | P | L | T | EC | P | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LTT | LTT | LTT | LTT | IFN-γ | IFN-γ | IFN-γ | IFN-γ | IL-10 | IL-10 | IL-10 | IL-10 | ||
Amino acid no. | Cut-off values for positivity Amino acid sequence | 2 SI > 1500 δ cpm | >χ + 2 SD > δ 20 pg/ml | >χ + 2 SD > δ 20 pg/ml | |||||||||
L1-15 | VAKVKIKPLEDKILV (ML) | 22 | |||||||||||
T1-15 | -----N--------- (MT) | 11 | |||||||||||
L11-25 | DKILVQAGEAETMTP (ML) | 11 | 10 | 25 | 20 | 25 | 11 | ||||||
T11-25 | -------N----T-A (MT) | 11 | 10 | 25 | 30 | 25 | 11 | ||||||
L21-35 | ETMTPSGLVIPENAK (ML) | 10 | 11 | 11 | 11 | 20 | 25 | ||||||
T21-35 | --T-A------DT-- (MT) | 10 | 11 | ||||||||||
L31-45 | PENAKEKPQEGTVVA (ML) | 11 | 10 | ||||||||||
T31-45 | -DT------------ (MT) | 11 | 11 | 22 | |||||||||
L51-65 | WDEDGAKRIPVDVSE (ML) | 10 | 11 | ||||||||||
T51-65 | ---------E-----L-A- (MT) | 11 | 10 | 11 | 11 | 10 | 22 | ||||||
L61-75 | VDVSEGDIVIYSKYG (ML) | 38 | 11 | 25 | 11 | 11 | 10 | ||||||
T61-75 | L-A----T------- (MT) | 13 | 11 | 10 | 25 | 11 | 11 | 11 | |||||
ML10K | >M. leprae | 33 | 40 | 50 | 11 | 44 | 50 | 63 | 33 | 78 | 90 | 88 | 67 |
MT10K | M. tuberculosis | 22 | 30 | 63 | 11 | 33 | 60 | 50 | 11 | 67 | 70 | 13 | 79 |
Italic data indicate concurrent recognition of ML and MT GroES peptides. Bold data indicate that responses were present only in leprosy patients to ML peptide only. All other details including the donors in each group are as described in Fig. 2.